Clinical Trial: RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL
Study Status: Completed
Recruit Status: RECRUITING
Condition: Neoplasms
Study Type: INTERVENTIONAL
Official Title: Efficacy, Safety and Cytopharmacokinetics of RD13-02 Cell Injection in the Treatment of Patients With Recurrent or Refractory CD7-positive Hematologic Malignancies
Brief Summary:
This is a single-arm, open-label, single-center, phase I study.The primary objective is to evaluate the safety of CD7 CAR-T therapy for patients with CD7-positive relapsed or refractory T-ALL/LBL, and to evaluate the pharmacokinetics of CD7 CAR-T in patients.
Read more